Xiaobin Lu
Overview
Explore the profile of Xiaobin Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1987
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu X
Heliyon
. 2023 Jun;
9(6):e16800.
PMID: 37292313
Fabricating a pit array on the surface of indium phosphide wafer can change its photoelectric properties, improve its photoelectric conversion efficiency, and expand its application range. There are few reviews...
2.
Shuai L, Zou X, Rao Y, Lu X, Yan H
Materials (Basel)
. 2022 Oct;
15(20).
PMID: 36295349
The effects of La and Y on the microstructure and mechanical properties of cast Al-Si-Cu alloys were investigated by X-ray diffractometer (XRD), optical microscope (OM), and scanning electron microscope (SEM)....
3.
Lu X
Sci Rep
. 2021 Jan;
11(1):1254.
PMID: 33441942
The content of trace impurities, such as interstitial oxygen and substitutional carbon, in silicon is crucial in determining the mechanical and physical characteristics of silicon wafers. The traditional infrared (IR)...
4.
Wan S, Lu X, Zhao H, Chen S, Cai S, He X, et al.
Materials (Basel)
. 2020 Feb;
13(5).
PMID: 32106395
Graphene oxide (GO) was modified by p-phenylenediamine (PPD), aiming at improving the wet-skid resistance and reduce the rolling loss of solution polymerized styrene-butadiene rubber (SSBR). PPD with amino groups enabled...
5.
OLeary M, Lu X, Huang Y, Lin X, Mahmood I, Przepiorka D, et al.
Clin Cancer Res
. 2018 Oct;
25(4):1142-1146.
PMID: 30309857
Tisagenlecleucel (Kymriah; Novartis Pharmaceuticals) is a CD19-directed genetically modified autologous T-cell immunotherapy. On August 30, 2017, the FDA approved tisagenlecleucel for treatment of patients up to 25 years of age...
6.
Li T, Shi Z, He X, Jiang P, Lu X, Zhang R, et al.
Materials (Basel)
. 2018 May;
11(5).
PMID: 29783656
With the aim of improving the anti-aging properties of nitrile-butadiene rubber (NBR), a functional organic filler, namely LDH⁻SAS, prepared by intercalating 4-amino-benzenesulfonic acid monosodium salt (SAS) into layered double hydroxides...
7.
Lu X, Yan Q, Ma Y, Guo X, Xiao S
Sci Rep
. 2016 Feb;
6:20291.
PMID: 26841692
Block copolymer nanolithography has attracted enormous interest in chip technologies, such as integrated silicon chips and biochips, due to its large-scale and mass production of uniform patterns. We further modified...
8.
Benetos A, Kimura M, Labat C, Buchoff G, Huber S, Labat L, et al.
Aging Cell
. 2011 Sep;
10(6):991-5.
PMID: 21917112
Recent studies have found associations of leukocyte telomere length (TL) with diseases of aging and with longevity. However, it is unknown whether birth leukocyte TL or its age-dependent attrition--the two...
9.
Kimura M, Stone R, Hunt S, Skurnick J, Lu X, Cao X, et al.
Nat Protoc
. 2010 Nov;
5(9):1596-607.
PMID: 21085125
In this protocol we describe a method to obtain telomere length parameters using Southern blots of terminal restriction fragments (TRFs). We use this approach primarily for epidemiological studies that examine...
10.
Levy D, Neuhausen S, Hunt S, Kimura M, Hwang S, Chen W, et al.
Proc Natl Acad Sci U S A
. 2010 Apr;
107(20):9293-8.
PMID: 20421499
Telomeres are engaged in a host of cellular functions, and their length is regulated by multiple genes. Telomere shortening, in the course of somatic cell replication, ultimately leads to replicative...